Medicare

A review of the 2025 Medicare Advantage plans available for individual enrollment shows that the total number of plans declined by 7% (from 3,959 to 3,699). The average Medicare beneficiary will have the option of 34 Medicare Advantage prescription drug (MA-PD) plans in 2025, just 2 fewer than the 36 options available in 2024. Since 2018, the number of plans available to the average beneficiary has doubled.

With the 2024 election season underway, a large majority of the public reports hearing false claims about immigrants from candidates or elected officials, and many immigrants say Donald Trump’s rhetoric in particular is negatively affecting how they are treated. This poll finding also gauges understanding about U.S. immigrants’ eligibility for government benefits programs.

With immigration and border security getting attention heading into November’s elections, a large majority of the public reports hearing false claims about immigrants from candidates or elected officials, and many immigrants say the rhetoric is negatively affecting how they are treated, a new KFF Health Misinformation Tracking Poll finds. Fielded…

Allowing Medicare to negotiate drug prices on behalf of older Americans remains broadly popular across partisans, though many voters are unaware of the new law and the billions of dollars it is expected to save in 2026, a new KFF Health Tracking Poll finds.A large majority (85%) of voters say…

In his latest column, KFF President and CEO Drew Altman explains why Medicaid, despite former President Donald Trump’s silence on the topic, warrants greater attention given the potential for drastic changes or cuts to it should Republicans win control in the election.

In 2024, federal spending on Medicare Advantage bonus payments will total at least $11.8 billion, as nearly three-quarters of enrollees are in a plan that received bonus payments. The average bonus payment is higher for employer plans and lowest for special needs plans, raising questions about the implication of the quality bonus program for equity.

Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…

This brief examines key facts around proposals to align Medicare payments for outpatient services across care settings, otherwise known as “site-neutral payment reforms.”

This Health Policy 101 chapter explores Medicare, a federal health insurance program covering more than 66 million people, established in 1965 for people age 65 or older and later expanded to cover people under age 65 with long-term disabilities. In addition to detailing Medicare eligibility, coverage, and spending, the chapter examines the increased role of private plans in providing benefits and the financing challenges posed by increasing health care costs and an aging population.